Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing Metformin Plus Megestrol Acetate with Megestrol Acetate Alone As a Fertility-sparing Treatment in Patients with Atypical Endometrial Hyperplasia

NCT04607252 is registered in ClinicalTrials.gov with Fudan University as lead sponsor.

NCT NCT04607252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04607252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing Metformin Plus Megestrol Acetate with Megestrol Acetate Alone As a Fertility-sparing Treatment in Patients with Atypical Endometrial Hyperplasia
Lead sponsor
Fudan University
Phase
Phase 2/3
Overall status
Terminated
Start date
January 11, 2021
Completion date
June 3, 2021
Enrollment
12 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atypical endometrial hyperplasia